Publication | Open Access
Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non‐B or Non‐C Hepatocellular Carcinoma
31
Citations
30
References
2014
Year
The present results suggest that AGE might be involved in the pathogenesis of NBNC-HCC, thereby being a biomarker that could discriminate NBNC-HCC from NASH.
| Year | Citations | |
|---|---|---|
Page 1
Page 1